echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 100 million yuan down payment!

    100 million yuan down payment!

    • Last Update: 2022-01-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ArticleMedicine Guanlan

    On November 22, Connoa announced that its wholly-owned subsidiary, Connoa Biomedical Technology (Chengdu) Co.


    CM326 is a class 1 innovative drug with a new mechanism of action developed by Chengdu Connoa, which targets thymic stromal lymphopoietin (TSLP)


    Pre-clinical studies have shown that CM326 has good safety and excellent efficacy.


    According to the agreement, Connoa will grant the exclusive license of CSPC CM326 to develop and commercialize the product in China (excluding Hong Kong, Macau and Taiwan) and become the holder of the marketing license


    Public information shows that this is another collaboration between Connoa and CSPC after signing an exclusive license for CM310


    According to the press release, CM326 is one of Connoa’s key products and has the potential to form complementary synergies with CM310 in this field


    Reference materials:

    [1] Information Express | Connoa authorized CSPC CM326 to develop and commercialize the exclusive license for moderate to severe asthma and chronic obstructive pulmonary disease (COPD) and other respiratory diseases.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.